Published on Feb 23, 2026
Nitrosamine regulations are the most impactful change to our industry in recent years, affecting 30% of current and new products, including generics. Regulatory expectations have changed frequently and vary globally. In this episode, Ella speaks to Jason Brown, Senior Analytical Sciences Manager at Adare Pharma Solutions, where he serves as the global nitrosamine subject matter expert. Jason discusses the future of nitrosamine detection and why it may not be as bad as first predicted.
Interesting in hearing more? Check out Jason's live webinar by clicking here.
Published on Feb 23, 2026 by Ella Thomas